SerbinCreative

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbincreative.com LA / NY / UK

AtEdge

AtEdge

Photography & Motion

Directory of Illustration

Directory of Illustration

Find the world's best illustrators

PLAY! Illustration

PLAY!

Illustration for Toys & Interactive Games

Lattis Social

Social Media for the Creative Industry

More from Serbin

JavaScript may be disabled in your browser. Please enable JavaScript for access to all site features.

Home
>
Artists
>
Kryski Biomedia

Kryski Biomedia

CLN2 Mechanism of Disease

ADA-SCID Mechanism of Disease

medical illustration of This series of panels shows the comparison of the breakdown of cellular waste in healthy cells vs cells with ceroid lipofuscinosis type 2 (CLN2). The bottom panel shows the MOA of the NAV technology, which uses an AAV to transport functional TPP1 into the CLN2 patient.

medical illustration of This molecular biology illustration shows a three-way comparison of the FGFR3 signalling pathway that regulates bone growth in normal, achondroplasia, and achondroplasia treated with TA-46. TA-46 is an investigational, soluble recombinant FGFR3 decoy in clinical trials by Therachon / Pfizer.

Mechanism of Action of TA-46 in Achondroplasia

This series of panels shows the comparison of the breakdown of cellular waste in healthy cells vs cells with ceroid lipofuscinosis type 2 (CLN2). The bottom panel shows the MOA of the NAV technology, which uses an AAV to transport functional TPP1 into the CLN2 patient.

Keywords: Color, Line with Color, Advertising / Marketing, Education, Product Demonstration, Cell biology / Histology, Genetics, Molecular Biology, Mechanism of Action (MOA), Pathology

© Diana Kryski